國家衛生研究院 NHRI:Item 3990099045/7698
English  |  正體中文  |  简体中文  |  全文笔数/总笔数 : 12145/12927 (94%)
造访人次 : 854031      在线人数 : 1419
RC Version 6.0 © Powered By DSPACE, MIT. Enhanced by NTU Library IR team.
搜寻范围 查询小技巧：
  • 您可在西文检索词汇前后加上"双引号"，以获取较精准的检索结果
  • 若欲以作者姓名搜寻，建议至进阶搜寻限定作者字段，可获得较完整数据
    •  进阶搜寻
    主页 ‧ 登入 ‧ 上传 ‧ 说明 ‧ 关于NHRI ‧ 管理 到手机版


    jsp.display-item.identifier=請使用永久網址來引用或連結此文件: http://ir.nhri.org.tw/handle/3990099045/7698


    题名: Leukemia inhibitory factor promotes nasopharyngeal carcinoma progression and radioresistance
    作者: Liu, SC;Tsang, NM;Chiang, WC;Chang, KP;Hsueh, C;Liang, Y;Juang, JL;Chow, KPN;Chang, YS
    贡献者: Institute of Molecular and Genomic Medicine
    摘要: Radioresistance of EBV-associated nasopharyngeal carcinoma (NPC) is associated with poor prognosis for patients with this form of cancer. Here, we found that NPC patients had increased serum levels of leukemia inhibitory factor (LIF) and that higher LIP levels correlated with local tumor recurrence. Furthermore, in vitro studies with NPC cells and in vivo xenograft mouse studies demonstrated that LIF critically contributes to NPC tumor growth and radioresistance. Using these model systems, we found that LIP treatment activated the mTORC1/p70S6K signaling pathway, enhanced tumor growth, inhibited DNA damage responses, and enhanced radioresistance. Treatment with either soluble LIF receptor (sLIFR), a LIP antagonist, or the mTOR inhibitor rapamycin reversed LIP-mediated effects, resulting in growth arrest and increased sensitivity to gamma irradiation. Immunohistochemical (IHC) analyses of human NPC biopsies revealed that LIF and LIFR were overexpressed in tumor cells and that LIP expression correlated with the presence of the activated p-p70S6K. Finally, we found that the EBV-encoded protein latent membrane protein 1 (LMP1) enhances LIP production. Together, our findings indicate that LIP promotes NPC tumorigenesis and suggest that serum LIP levels may predict local recurrence and radiosensitivity in NPC patients.
    日期: 2013-12-02
    關聯: Journal of Clinical Investigation. 2013 Dec 2;123(12):5269-5283.
    Link to: http://dx.doi.org/10.1172/jci63428ds1
    JIF/Ranking 2023: http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcAuth=NHRI&SrcApp=NHRI_IR&KeyISSN=0021-9738&DestApp=IC2JCR
    Cited Times(WOS): https://www.webofscience.com/wos/woscc/full-record/WOS:000327826100031
    Cited Times(Scopus): http://www.scopus.com/inward/record.url?partnerID=HzOxMe3b&scp=84890110205
    显示于类别:[莊志立] 期刊論文

    文件中的档案:

    档案 描述 大小格式浏览次数
    PB2013122402.pdf7543KbAdobe PDF702检视/开启


    在NHRI中所有的数据项都受到原著作权保护.

    TAIR相关文章

    DSpace Software Copyright © 2002-2004  MIT &  Hewlett-Packard  /   Enhanced by   NTU Library IR team Copyright ©   - 回馈